Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lieb, Klaus ^a   Scheurich, Armin ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; CLINICAL PRACTICE; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; FEMALE; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HUMAN; INFORMATION DISSEMINATION; MALE; MEDICAL EDUCATION; NORMAL HUMAN; ONLINE SYSTEM; PATENT; PERCEPTION; PHARMACEUTICAL SALES REPRESENTATIVE; PHYSICIAN ATTITUDE; PRESCRIPTION; QUESTIONNAIRE; SOCIAL INTERACTION; CONTINUING EDUCATION; ECONOMICS; HABIT; HEALTH PERSONNEL ATTITUDE; HUMAN RELATION; PHYSICIAN; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; DRUG PRESCRIPTIONS; EDUCATION, CONTINUING; HABITS; HUMANS; INTERPERSONAL RELATIONS; PATENTS AS TOPIC; PERCEPTION; PHYSICIANS; QUESTIONNAIRES;

EID: 84908042699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110130     Document Type: Article

References (20)

1. Korzilius H, Rieser S (2007) Pharmaberater: Für manche Fachmann, für andere Buhmann. Deutsches Ärzteblatt 104: 143-6.
2. Lieb K, Brandtönies S (2010) A Survey of German Physicians in Private Practice About Contacts With Pharmaceutical Sales Representatives. Dtsch Arztebl Int 107: 392-8.
3. Avorn J, Chen M, Hartley R (1982) Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 73: 4-8.
4. Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM (1972) Differential education concerning therapeutics and resultant physician prescribing patterns. J Med Educ 47: 118-27.
5. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, et al. (2010) Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review. PLoS Med 7(10): e1000352.
6. Darlington RB (1990) Multiple Tests. In: Darlington RB (ed.). Regression and linear models (249-276). New York: McGraw-Hill.
7. Available: http://www.kvb.de/partner/versorgungsatlas/?sword-list[]=versorgungsatlas&no-cache=1. Accessed May 25, 2014.
8. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, et al. (2007) A national survey of physician-industry relationships. New England Journal of Medicine 356: 1742-50.
9. Campbell EG, Rao SR, DesRoches CM, Iezzoni LI, Vogeli C, et al. (2010) Physician Professionalism and Changes in Physician-Industry Relationships from 2004 to 2009. Arch Intern Med 170: 1820-1826.
10. Steinman M, Shlipak M, MacPhee S (2001) Of Principles and Pens: Attitudes and Practices of Medicine Housestaff toward Pharmaceutical Industry Promotions. American Journal of Medicine 110: 551-7.
11. Pronin E, Gilovich T, Ross L (2004) Objectivity in the Eye of the Beholder: Divergent Perceptions of Bias in Self Versus Others. Psychological Review 111: 781-799.
12. Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, et al. (1990) Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 5: 240-3.
13. Caamaño F, Figueiras A, Gestal-Otero JJ (2002) Influence of commercial information on prescription quantity in primary care. Eur J Public Health 12: 187-91.
14. Watkins C, Harvey I, Carthy P, Moore L, Robinson E, et al. (2003) Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Quality & safety in health care 12: 29-34.
15. Lexchin J (2012) Of money and trust in medical care redux. Mens Sana Monogr 10: 143-9.
16. Orlowski JP, Wateska L (1992) The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. CHEST 102: 270-3.
17. Bowman MA, Pearle DL (1988) Changes in drug prescribing patterns related to commercial company funding of continuing medical education. Journal of Continuing Education in the Health Professions 8: 13-20.
18. Chren MM, Landefeld CS (1994) Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. Journal of the American Medical Association 271: 684-9.
19. Rodwin MA (2010) Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal. J Law Med Ethics 38: 807-15.
20. Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, et al. (2013) Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. J Gen Intern Med. 28: 1368-75.